Acoustic neuroma treatment focuses on controlling tumor growth, preserving nerve function, and maintaining quality of life through careful observation, precise radiation techniques, or surgical removal, depending on each person’s unique situation.

Understanding Your Treatment Path

When someone receives a diagnosis of acoustic neuroma, also called vestibular schwannoma, the main goal of treatment is not always to remove the tumor immediately. Because these growths are noncancerous (benign) and often grow very slowly, the focus shifts to managing symptoms, protecting hearing and facial nerve function, and preventing complications that could affect balance or other vital functions.^[1][2]

Treatment decisions depend heavily on several factors unique to each patient. The size of the tumor matters greatly—small tumors may not need immediate intervention, while larger ones pressing on the brain or nerves require more urgent attention. The speed at which the tumor is growing, as seen on repeated imaging scans, helps doctors predict future problems. A patient’s age and overall health also play important roles, since some treatments carry risks that may not be suitable for everyone. Finally, the impact on hearing and balance helps determine which approach will best preserve quality of life.^[5]

Medical societies have established standard guidelines for treating acoustic neuroma based on decades of experience and research. These approved methods include regular monitoring through imaging, focused radiation therapy, and various surgical techniques. At the same time, researchers continue exploring new therapies through clinical trials—organized studies that test innovative drugs and treatment approaches. These trials aim to find ways to shrink tumors, preserve hearing longer, or reduce side effects from existing treatments.^[2][3]

Standard Treatment Approaches

The most conservative treatment option is called “observation” or “watchful waiting.” This approach makes sense for small tumors that aren’t causing significant symptoms or for patients whose age or health conditions make other treatments too risky. During observation, patients undergo regular magnetic resonance imaging (MRI) scans—typically every six to twelve months—to track whether the tumor is growing. Hearing tests also help monitor any changes in nerve function. This strategy recognizes that many acoustic neuromas grow so slowly they may never cause serious problems during a person’s lifetime. The key advantage is avoiding unnecessary treatment risks, though patients must accept living with an untreated tumor and attending frequent follow-up appointments.^[2][4]

Stereotactic radiosurgery represents a modern radiation treatment that delivers highly focused beams of radiation to the tumor while protecting surrounding healthy tissue. Despite its name, this isn’t actually surgery—no incisions are made. The most common form is Gamma Knife radiosurgery, though other systems like CyberKnife also exist. During treatment, radiation beams converge precisely on the tumor from multiple angles, damaging the tumor cells’ ability to grow and divide. The goal isn’t to make the tumor disappear immediately but to stop its growth over time. Many tumors actually shrink slowly after radiation.^[2][5]

Radiation therapy works best for small to medium-sized tumors, typically those less than 3 centimeters in diameter. The treatment itself usually happens in a single session lasting several hours, though some centers use multiple smaller doses over several days. Patients return home the same day. Over the following months and years, regular MRI scans monitor the tumor’s response. Studies show that radiation successfully controls tumor growth in about 90-95% of appropriately selected patients.^[2][6]

Surgical removal remains the only treatment that can completely eliminate an acoustic neuroma. Neurosurgeons use specialized microsurgery techniques, operating through small openings in the skull with the help of high-powered microscopes and delicate instruments. There are several surgical approaches, each chosen based on tumor size, location, and whether preserving hearing is possible. The translabyrinthine approach goes through the bone behind the ear and sacrifices hearing in that ear, but provides excellent access to the tumor and the best chance of preserving facial nerve function. The retrosigmoid approach (also called suboccipital) enters from the back of the skull and may allow hearing preservation in carefully selected patients with small tumors and good hearing before surgery. A third option, the middle fossa approach, is used only for very small tumors in patients with excellent hearing.^[2][7][8]

Surgery typically requires several days of hospitalization. The operation itself takes anywhere from four to eight hours depending on tumor size and complexity. Surgeons work painstakingly to separate the tumor from the facial nerve, which controls muscle movement in the face, and the balance and hearing nerves. Complete tumor removal is achieved in most cases, though surgeons sometimes intentionally leave tiny fragments attached to the facial nerve to avoid permanent paralysis. Recovery involves managing postoperative headaches, dizziness, and temporary balance problems. Most patients resume normal activities within four to six weeks, though complete recovery takes longer.^[5][8]

The most significant risk of acoustic neuroma surgery is facial nerve damage. Even in experienced hands, some degree of temporary facial weakness occurs in many patients, though permanent paralysis happens in less than 5% of cases for small tumors at specialized centers. The risk increases with tumor size—large tumors pressing on the facial nerve for years make preservation more difficult. Hearing loss on the affected side is common, especially with larger tumors or certain surgical approaches. Balance problems typically improve over several months as the brain adapts, though some patients experience lasting unsteadiness. Other potential complications include cerebrospinal fluid leaks, infection, and rarely, stroke.^[5][8]

For patients who experience persistent balance problems after any treatment, vestibular rehabilitation therapy offers significant help. This specialized physical therapy program teaches the brain to compensate for the lost balance function from the affected ear. Through specific head and eye movement exercises, patients gradually improve their stability, reduce dizziness, and regain confidence in daily activities. Many people benefit from working with a physical therapist trained in vestibular disorders for several weeks or months.^[2][7]

Emerging Treatments in Clinical Trials

While surgery and radiation remain the mainstays of acoustic neuroma treatment, researchers are actively investigating new approaches through clinical trials. These studies explore whether medications might offer alternatives, particularly for patients who cannot undergo surgery or radiation, or for those with tumors associated with the genetic condition neurofibromatosis type 2 (NF2), which causes tumors to grow on both sides.^[3][4]

The most promising drug currently being studied is bevacizumab (marketed under brand names including Avastin, Mvasi, Zirabev, and Alymsys). This medication works as a vascular endothelial growth factor (VEGF) inhibitor—it blocks the signals that tumors use to grow new blood vessels. Without an adequate blood supply, tumors may stop growing or even shrink. Bevacizumab is already approved by regulatory authorities for treating various cancers, but its use for acoustic neuromas remains experimental and “off-label.”^[2][7]

Clinical trials have shown that bevacizumab can shrink acoustic neuromas in some patients with NF2, and more importantly, may help preserve hearing in children and young adults whose tumors are threatening their remaining hearing. The drug is given through intravenous infusion, typically every two to three weeks, over an extended period. However, bevacizumab does not cure the tumor—once treatment stops, tumors often begin growing again. The medication also carries potential side effects including high blood pressure, protein in the urine, increased risk of bleeding, and wound healing problems. For these reasons, doctors carefully select which patients might benefit from this therapy.^[2][7]

Beyond bevacizumab, researchers are exploring other potential drug targets. Some clinical trials are investigating whether drugs that block specific growth signals inside tumor cells—called targeted molecular therapies—might slow acoustic neuroma growth. These medications aim to interfere with the abnormal cell signaling caused by mutations in the NF2 gene or related pathways. Early-phase trials (Phase I and Phase II studies) are testing the safety and preliminary effectiveness of these agents. Results remain preliminary, and these drugs are not yet available outside of research settings.^[3]

Another area of investigation involves using bevacizumab to treat radiation necrosis—a rare but serious complication where previously radiated tissue in the brain becomes damaged and swollen months or years after radiation therapy. Some clinical centers have reported that bevacizumab can reduce swelling and symptoms in patients who develop this complication, potentially avoiding the need for additional surgery.^[2][7]

Clinical trials for acoustic neuroma are ongoing in multiple countries including the United States, Europe, and other regions. Patients interested in participating need to meet specific eligibility criteria, which typically include factors like tumor size, growth rate, hearing status, previous treatments, and overall health. Some trials specifically recruit patients with NF2, while others focus on sporadic (non-inherited) acoustic neuromas. Trial phases matter—Phase I studies primarily test safety in small groups, Phase II studies evaluate whether a treatment shows promise of working, and Phase III studies compare new treatments directly against current standards in larger patient populations.^[3]

Most common treatment methods

• Observation (watchful waiting)
  • Regular MRI scans every six to twelve months to monitor tumor growth
  • Periodic hearing tests to track nerve function changes
  • Appropriate for small, slow-growing tumors causing minimal symptoms
  • Avoids treatment risks but requires ongoing monitoring commitment
• Stereotactic radiosurgery
  • Highly focused radiation beams targeting the tumor from multiple angles
  • Common systems include Gamma Knife and CyberKnife
  • Usually performed in a single session lasting several hours
  • Aims to stop tumor growth rather than immediate shrinkage
  • Effective for small to medium tumors (typically under 3 cm)
  • Controls growth in approximately 90-95% of appropriately selected patients
• Microsurgical removal
  • Translabyrinthine approach through bone behind the ear, sacrifices hearing but protects facial nerve
  • Retrosigmoid (suboccipital) approach from back of skull, may preserve hearing in selected patients
  • Middle fossa approach for very small tumors with excellent pre-existing hearing
  • Complete removal achieved in most cases
  • Requires several days hospitalization and weeks of recovery
  • Risks include facial nerve weakness, hearing loss, and balance problems
• Chemotherapy (experimental)
  • Bevacizumab (Avastin, Mvasi, Zirabev, Alymsys) blocks tumor blood vessel growth
  • May shrink tumors in patients with neurofibromatosis type 2
  • Can help preserve hearing in children and young adults
  • Given through intravenous infusion every two to three weeks
  • Tumors may regrow when treatment stops
  • Also used to treat radiation-induced tissue damage (necrosis)
• Vestibular rehabilitation therapy
  • Specialized physical therapy for balance problems after treatment
  • Teaches brain to compensate for lost inner ear function
  • Uses specific head and eye movement exercises
  • Typically conducted over several weeks to months
  • Improves stability and reduces dizziness